Retifanlimab (Anti-PDCD1 / PD-1 / CD279)
Retifanlimab (Anti-PDCD1 / PD-1 / CD279) is a monoclonal antibody targeting programmed cell death protein 1 (anti-PD-1). It can be used for the research of gastroesophageal adenocarcinoma (GEA). MW :145.64 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A3037 |
Sku # | A3037-1mg*5 |
Pricing | 1mg*5, $970.00 |